Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector

Clinical trial NCT05264493 · COMPLETED

Trial details

NCT number: NCT05264493
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2020-10-06
Primary completion: 2021-01-08
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.